At $369.57, Tesla (NASDAQ:TSLA | TSLA Price Prediction) looks overvalued, because the multiple asks investors to underwrite three uninvented businesses while the core auto operation decelerates. With Q2 results imminent, the gap between narrative and accounting has rarely been wider.
Tesla still earns most of its money making electric vehicles, with a growing energy storage arm and fast-scaling services including Full Self-Driving subscriptions. The story running the stock, however, is Robotaxi, Optimus, and in-house AI silicon. Shares are down 17.82% year to date and sit below both the 50-day ($409.80) and 200-day ($417.05) moving averages, well off the 52-week high of $498.83.
Why the Margin Recovery Could Reignite the Story
Q1 2026 delivered the operational turn bulls have been waiting for. EPS came in at $0.41 versus $0.3592 expected, revenue grew 15.78% year over year, and automotive gross margin snapped back to 21.1% from 16.2%. Services revenue jumped 42%, and FSD paid subscribers reached roughly 1.3 million, up 51% year over year.
The balance sheet remains a fortress at $44.7 billion in cash against modest debt, and prediction markets assign an 80% probability of another earnings beat on July 22. Management believes Optimus will be “the biggest product ever”, and if even a fraction of that optionality clears, today’s price will look cheap.
Why the Accounting Refuses to Justify the Multiple
Strip out the speculative narratives and the fundamentals are those of an increasingly commoditized auto manufacturer. FY2025 net income fell 46.79%, Q4 deliveries dropped 16% to 418,227 units, and regulatory credits keep shrinking. Operating expenses grew 37% year over year in Q1 on AI spend and CEO stock-based comp.
Valuation sits at 346 trailing P/E and 167 forward P/E, with a PEG of 5 and EV/EBITDA of 116. Prediction markets price Optimus release by year-end at just 16%, California robotaxi at 18.5%, and Robovan orders at 7%. CFO Vaibhav Taneja guided to over $25 billion of CapEx and negative free cash flow for the rest of the year.
Why Patience Might Beat Conviction Either Way
The Hold argument rests on catalyst density. Q2 deliveries returned to growth, an EU FSD expansion is progressing, and AI5 tape-out cleared in April. Analyst consensus splits 23 Buy/Strong Buy, 18 Hold, and 6 Sell/Strong Sell across 47 shops, defining an unresolved debate.
Musk conceded Optimus production this year is “impossible to predict” and Robotaxi revenue will not be “super material this year”. Waiting one or two prints for hard Optimus unit economics, Robotaxi safety data, and clarity on AI CapEx payback lets investors avoid paying peak narrative premium ahead of proof.
What the Tape and the Street Actually Say
Shares currently trade near $369.57 against an average analyst price target of $425.22, implying roughly 15% upside from a pool of 47 analysts. Targets are one data point among many.
Year to date, TSLA is down 17.82% while the S&P 500 is up 8.82%. Over one year, TSLA is up 12.11% versus 18.25% for the index. Prediction markets give the stock only a 48% chance of closing July above $370.
Why $370 Looks Stretched
At $370, Tesla is a Sell.
The path to further downside is straightforward. Consensus already models roughly $27.6 billion in Q2 revenue and $1.27 billion in net income, and CapEx guidance points to negative free cash flow into 2027. If Q2 confirms an earnings beat but defers Optimus unit economics and California robotaxi timing, the multiple has room to compress toward the forward P/E of 167, still egregious but painful from here.
Likely triggers over the next two quarters are further regulatory credit erosion, a fifth consecutive quarter of operating expense growth above 30%, and continued inventory build from the current 27 days of supply. A hard Optimus production milestone, an approved California robotaxi permit, or genuine FSD margin disclosure would invalidate the thesis.
The core problem is that owners at $370 are paying an enterprise software multiple for a business currently generating auto-manufacturer margins, and Musk himself will not commit to when that changes. At current levels, the risk/reward skews unfavorably.
Contact [email protected] for any questions or corrections.
Top Gaining Stocks
Top Losing Stocks